Clincosm LogoSign in Get a demo

gastroenteropancreatic neuroendocrine tumor

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastroenteropancreatic Neuroendocrine Tumours

Recruiting
  • Gastroenteropancreatic Neuroendocrine Tumor
  • 68Ga-DOTATOC PET as a part of their clinical diagnostic work-up will be included
  • Milano, Italy
    Irccs San Raffaele
Nov 24, 2023

Gastroenteropancreatic Neuroendocrine Tumor Trial in Belgium, Netherlands (Somatostatin analog)

Not yet recruiting
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Somatostatin analog
  • Brasschaat, Antwerp, Belgium
  • +19 more
Jan 31, 2023

Gastroenteropancreatic Neuroendocrine Tumor Trial in China (Lanreotide autogel)

Completed
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Lanreotide autogel
  • Sichuan, Chengdu, China
  • +13 more
Jan 16, 2023

Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,

Recruiting
  • Advanced Solid Tumors
  • +11 more
  • Boston, Massachusetts
  • +4 more
Dec 12, 2022

Gastroenteropancreatic Neuroendocrine Tumor Trial in Stanford (Lutathera, Gallium 68 Dotatate, Computed Tomography (CT))

Suspended
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Stanford, California
    Stanford Cancer Institute Palo Alto
Sep 21, 2022

Neuroendocrine Tumors, Carcinoid Tumor, Pulmonary Carcinoid Tumor Trial in Vancouver (177Lu-DOTATOC)

Not yet recruiting
  • Neuroendocrine Tumors
  • +6 more
  • Vancouver, British Columbia, Canada
    BC Cancer
Aug 19, 2022

Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Trial in Cleveland (TQ Formula (black

Not yet recruiting
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Gastroenteropancreatic Neuroendocrine Neoplasm
  • TQ Formula (black seed oil capsules)
  • +2 more
  • Cleveland, Ohio
    University hospitals Seidman Cancer Center, Case Comprehensive C
Aug 12, 2022

GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease Trial in United States

Recruiting
  • GEP-NET
  • +6 more
  • Duarte, California
  • +3 more
Jul 28, 2022

Neuroendocrine Tumors - Patient Reported Outcomes

Enrolling by invitation
  • Neuroendocrine Tumors
  • +3 more
    • Gainesville, Florida
    • +13 more
    Jul 7, 2022

    Effectiveness and Outcomes Associated With Lutathera Treatment

    Active, not recruiting
    • Gastroenteropancreatic Neuroendocrine Tumor
    • Alessandria, Italy
    • +17 more
    May 4, 2022

    Nutrition in Gastroenteropancreatic Neuroendocrine Tumor

    Active, not recruiting
    • Gastroenteropancreatic Neuroendocrine Tumor
      • El Palmar, Murcia, Spain
      • +15 more
      Feb 16, 2022

      Assay asBiomarker for Gastroenteropancreatic and Lung

      Completed
      • Gastroenteropancreatic Neuroendocrine Tumor
      • Lung Neuroendocrine Neoplasm
      • NETest
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Aug 3, 2021

      Gastroenteropancreatic Neuroendocrine Tumor Trial in Beijing (Famitinib)

      Terminated
      • Gastroenteropancreatic Neuroendocrine Tumor
      • Beijing, China
        Cancer Institute and Hospital, Chinese Academy of Medical Scienc
      Jan 17, 2019

      Lanreotide and Octreotide Long Acting Release for Advanced

      Completed
      • Gastroenteropancreatic Neuroendocrine Tumor
        • Tucson, Arizona
        • +4 more
        Dec 20, 2018